<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2017-11-22" version="203">
<accession>P36507</accession>
<name>MP2K2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Dual specificity mitogen-activated protein kinase kinase 2</fullName>
<shortName>MAP kinase kinase 2</shortName>
<shortName>MAPKK 2</shortName>
<ecNumber evidence="14">2.7.12.2</ecNumber>
</recommendedName>
<alternativeName>
<fullName>ERK activator kinase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>MAPK/ERK kinase 2</fullName>
<shortName>MEK 2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">MAP2K2</name>
<name type="synonym">MEK2</name>
<name type="synonym">MKK2</name>
<name type="synonym">PRKMK2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="11435" last="11439">
<title>Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2.</title>
<authorList>
<person name="Zheng C.-F."/>
<person name="Guan K.-L."/>
</authorList>
<dbReference type="PubMed" id="8388392"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Muscle</tissue>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Zebisch A."/>
<person name="Kolch W."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 40-51; 53-61; 64-100; 102-112; 164-172; 194-205; 265-297; 362-371 AND 389-397</scope>
<scope>PHOSPHORYLATION AT THR-394</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="18574" last="18579">
<title>Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling.</title>
<authorList>
<person name="Mittal R."/>
<person name="Peak-Chew S.Y."/>
<person name="McMahon H.T."/>
</authorList>
<dbReference type="PubMed" id="17116858"/>
<dbReference type="DOI" id="10.1073/pnas.0608995103"/>
</citation>
<scope>PROTEIN SEQUENCE OF 210-231</scope>
<scope>INACTIVATION BY YERSINIA YOPJ</scope>
<scope>PHOSPHORYLATION AT SER-222 AND SER-226</scope>
<scope>ACETYLATION AT SER-222 AND SER-226</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1998" name="Science" volume="280" first="734" last="737">
<title>Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor.</title>
<authorList>
<person name="Duesbery N.S."/>
<person name="Webb C.P."/>
<person name="Leppla S.H."/>
<person name="Gordon V.M."/>
<person name="Klimpel K.R."/>
<person name="Copeland T.D."/>
<person name="Ahn N.G."/>
<person name="Oskarsson M.K."/>
<person name="Fukasawa K."/>
<person name="Paull K.D."/>
<person name="Vande Woude G.F."/>
</authorList>
<dbReference type="PubMed" id="9563949"/>
<dbReference type="DOI" id="10.1126/science.280.5364.734"/>
</citation>
<scope>CLEAVAGE BY ANTHRAX LETHAL FACTOR</scope>
</reference>
<reference key="6">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5523" last="5534">
<title>Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization.</title>
<authorList>
<person name="Stewart S."/>
<person name="Sundaram M."/>
<person name="Zhang Y."/>
<person name="Lee J."/>
<person name="Han M."/>
<person name="Guan K.L."/>
</authorList>
<dbReference type="PubMed" id="10409742"/>
<dbReference type="DOI" id="10.1128/MCB.19.8.5523"/>
</citation>
<scope>PROTEIN SEQUENCE OF 39-49; 52-61 AND 352-361</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
<scope>INTERACTION WITH KSR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-222</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2000" name="Biochem. J." volume="352" first="739" last="745">
<title>Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.</title>
<authorList>
<person name="Vitale G."/>
<person name="Bernardi L."/>
<person name="Napolitani G."/>
<person name="Mock M."/>
<person name="Montecucco C."/>
</authorList>
<dbReference type="PubMed" id="11104681"/>
<dbReference type="DOI" id="10.1042/bj3520739"/>
</citation>
<scope>CLEAVAGE BY ANTHRAX LETHAL FACTOR</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293 AND SER-295</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND THR-396</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="12">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2009" name="J. Hepatol." volume="51" first="67" last="76">
<title>Protein kinase SGK1 enhances MEK/ERK complex formation through the phosphorylation of ERK2: implication for the positive regulatory role of SGK1 on the ERK function during liver regeneration.</title>
<authorList>
<person name="Won M."/>
<person name="Park K.A."/>
<person name="Byun H.S."/>
<person name="Kim Y.R."/>
<person name="Choi B.L."/>
<person name="Hong J.H."/>
<person name="Park J."/>
<person name="Seok J.H."/>
<person name="Lee Y.H."/>
<person name="Cho C.H."/>
<person name="Song I.S."/>
<person name="Kim Y.K."/>
<person name="Shen H.M."/>
<person name="Hur G.M."/>
</authorList>
<dbReference type="PubMed" id="19447520"/>
<dbReference type="DOI" id="10.1016/j.jhep.2009.02.027"/>
</citation>
<scope>INTERACTION WITH SGK1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-295 AND THR-394</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND THR-396</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND THR-396</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23 AND THR-396</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2006" name="Science" volume="311" first="1287" last="1290">
<title>Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.</title>
<authorList>
<person name="Rodriguez-Viciana P."/>
<person name="Tetsu O."/>
<person name="Tidyman W.E."/>
<person name="Estep A.L."/>
<person name="Conger B.A."/>
<person name="Cruz M.S."/>
<person name="McCormick F."/>
<person name="Rauen K.A."/>
</authorList>
<dbReference type="PubMed" id="16439621"/>
<dbReference type="DOI" id="10.1126/science.1124642"/>
</citation>
<scope>VARIANT CFC4 CYS-57</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Clin. Genet." volume="73" first="62" last="70">
<title>Mutation and phenotypic spectrum in patients with cardio-facio-cutaneous and Costello syndrome.</title>
<authorList>
<person name="Schulz A.L."/>
<person name="Albrecht B."/>
<person name="Arici C."/>
<person name="van der Burgt I."/>
<person name="Buske A."/>
<person name="Gillessen-Kaesbach G."/>
<person name="Heller R."/>
<person name="Horn D."/>
<person name="Hubner C.A."/>
<person name="Korenke G.C."/>
<person name="Konig R."/>
<person name="Kress W."/>
<person name="Kruger G."/>
<person name="Meinecke P."/>
<person name="Mucke J."/>
<person name="Plecko B."/>
<person name="Rossier E."/>
<person name="Schinzel A."/>
<person name="Schulze A."/>
<person name="Seemanova E."/>
<person name="Seidel H."/>
<person name="Spranger S."/>
<person name="Tuysuz B."/>
<person name="Uhrig S."/>
<person name="Wieczorek D."/>
<person name="Kutsche K."/>
<person name="Zenker M."/>
</authorList>
<dbReference type="PubMed" id="18042262"/>
<dbReference type="DOI" id="10.1111/j.1399-0004.2007.00931.x"/>
</citation>
<scope>VARIANTS CFC4 VAL-57 AND HIS-134</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Am. J. Med. Genet. A" volume="152" first="807" last="814">
<title>Molecular and functional analysis of a novel MEK2 mutation in cardio-facio-cutaneous syndrome: transmission through four generations.</title>
<authorList>
<person name="Rauen K.A."/>
<person name="Tidyman W.E."/>
<person name="Estep A.L."/>
<person name="Sampath S."/>
<person name="Peltier H.M."/>
<person name="Bale S.J."/>
<person name="Lacassie Y."/>
</authorList>
<dbReference type="PubMed" id="20358587"/>
<dbReference type="DOI" id="10.1002/ajmg.a.33342"/>
</citation>
<scope>VARIANT CFC4 GLN-128</scope>
<scope>CHARACTERIZATION OF VARIANT CFC4 GLN-128</scope>
</reference>
<comment type="function">
<text evidence="9">Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases (By similarity).</text>
</comment>
<comment type="catalytic activity">
<text evidence="14">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="14">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="subunit">
<text evidence="11 14 18">Interacts with MORG1 (By similarity). Interacts with SGK1 (PubMed:19447520). Interacts with KSR1 (PubMed:10409742).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056930"/>
<interactant intactId="EBI-365961">
<id>P10398</id>
<label>ARAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056930"/>
<interactant intactId="EBI-365980">
<id>P15056</id>
<label>BRAF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056930"/>
<interactant intactId="EBI-748961">
<id>O95273</id>
<label>CCNDBP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056930"/>
<interactant intactId="EBI-357481">
<id>Q12959</id>
<label>DLG1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056930"/>
<interactant intactId="EBI-486984">
<id>Q8IVT5</id>
<label>KSR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1056930"/>
<interactant intactId="EBI-365996">
<id>P04049</id>
<label>RAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="14">Membrane</location>
<topology evidence="14">Peripheral membrane protein</topology>
</subcellularLocation>
<text evidence="14">Membrane localization is probably regulated by its interaction with KSR1.</text>
</comment>
<comment type="PTM">
<text evidence="9">MAPKK is itself dependent on Ser/Thr phosphorylation for activity catalyzed by MAP kinase kinase kinases (RAF or MEKK1). Phosphorylated by MAP2K1/MEK1 (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="16 20">Acetylation of Ser-222 and Ser-226 by Yersinia yopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway.</text>
</comment>
<comment type="disease" evidence="15 17 19">
<disease id="DI-03781">
<name>Cardiofaciocutaneous syndrome 4</name>
<acronym>CFC4</acronym>
<description>A form of cardiofaciocutaneous syndrome, a multiple congenital anomaly disorder characterized by a distinctive facial appearance, heart defects and mental retardation. Heart defects include pulmonic stenosis, atrial septal defects and hypertrophic cardiomyopathy. Some affected individuals present with ectodermal abnormalities such as sparse, friable hair, hyperkeratotic skin lesions and a generalized ichthyosis-like condition. Typical facial features are similar to Noonan syndrome. They include high forehead with bitemporal constriction, hypoplastic supraorbital ridges, downslanting palpebral fissures, a depressed nasal bridge, and posteriorly angulated ears with prominent helices.</description>
<dbReference type="MIM" id="615280"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="21">Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase subfamily.</text>
</comment>
<dbReference type="EC" id="2.7.12.2" evidence="14"/>
<dbReference type="EMBL" id="L11285">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000471">
<property type="protein sequence ID" value="AAH00471.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC018645">
<property type="protein sequence ID" value="AAH18645.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12120.1"/>
<dbReference type="PIR" id="A46723">
<property type="entry name" value="A46723"/>
</dbReference>
<dbReference type="RefSeq" id="NP_109587.1">
<property type="nucleotide sequence ID" value="NM_030662.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.465627"/>
<dbReference type="PDB" id="1S9I">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="A/B=55-400"/>
</dbReference>
<dbReference type="PDB" id="4H3Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="B=4-16"/>
</dbReference>
<dbReference type="PDBsum" id="1S9I"/>
<dbReference type="PDBsum" id="4H3Q"/>
<dbReference type="ProteinModelPortal" id="P36507"/>
<dbReference type="SMR" id="P36507"/>
<dbReference type="BioGrid" id="111591">
<property type="interactions" value="43"/>
</dbReference>
<dbReference type="CORUM" id="P36507"/>
<dbReference type="DIP" id="DIP-29119N"/>
<dbReference type="IntAct" id="P36507">
<property type="interactions" value="22"/>
</dbReference>
<dbReference type="MINT" id="MINT-99667"/>
<dbReference type="STRING" id="9606.ENSP00000262948"/>
<dbReference type="BindingDB" id="P36507"/>
<dbReference type="ChEMBL" id="CHEMBL2964"/>
<dbReference type="DrugBank" id="DB06616">
<property type="generic name" value="Bosutinib"/>
</dbReference>
<dbReference type="DrugBank" id="DB08911">
<property type="generic name" value="Trametinib"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="2063"/>
<dbReference type="iPTMnet" id="P36507"/>
<dbReference type="PhosphoSitePlus" id="P36507"/>
<dbReference type="SwissPalm" id="P36507"/>
<dbReference type="BioMuta" id="MAP2K2"/>
<dbReference type="DMDM" id="547915"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00003783"/>
<dbReference type="EPD" id="P36507"/>
<dbReference type="MaxQB" id="P36507"/>
<dbReference type="PaxDb" id="P36507"/>
<dbReference type="PeptideAtlas" id="P36507"/>
<dbReference type="PRIDE" id="P36507"/>
<dbReference type="DNASU" id="5605"/>
<dbReference type="Ensembl" id="ENST00000262948">
<property type="protein sequence ID" value="ENSP00000262948"/>
<property type="gene ID" value="ENSG00000126934"/>
</dbReference>
<dbReference type="GeneID" id="5605"/>
<dbReference type="KEGG" id="hsa:5605"/>
<dbReference type="UCSC" id="uc002lzk.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5605"/>
<dbReference type="DisGeNET" id="5605"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000126934.13"/>
<dbReference type="GeneCards" id="MAP2K2"/>
<dbReference type="GeneReviews" id="MAP2K2"/>
<dbReference type="H-InvDB" id="HIX0033655"/>
<dbReference type="HGNC" id="HGNC:6842">
<property type="gene designation" value="MAP2K2"/>
</dbReference>
<dbReference type="HPA" id="CAB003835"/>
<dbReference type="HPA" id="HPA051993"/>
<dbReference type="MalaCards" id="MAP2K2"/>
<dbReference type="MIM" id="601263">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="615280">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P36507"/>
<dbReference type="OpenTargets" id="ENSG00000126934"/>
<dbReference type="Orphanet" id="1340">
<property type="disease" value="Cardiofaciocutaneous syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="638">
<property type="disease" value="Neurofibromatosis-Noonan syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA30587"/>
<dbReference type="eggNOG" id="KOG0581">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQ5A">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119199"/>
<dbReference type="HOGENOM" id="HOG000234206"/>
<dbReference type="HOVERGEN" id="HBG108518"/>
<dbReference type="InParanoid" id="P36507"/>
<dbReference type="KO" id="K04369"/>
<dbReference type="OMA" id="IAGWVCK"/>
<dbReference type="OrthoDB" id="EOG091G0DEC"/>
<dbReference type="PhylomeDB" id="P36507"/>
<dbReference type="TreeFam" id="TF105137"/>
<dbReference type="BRENDA" id="2.7.12.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-112411">
<property type="pathway name" value="MAPK1 (ERK2) activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445144">
<property type="pathway name" value="Signal transduction by L1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5210891">
<property type="pathway name" value="Uptake and function of anthrax toxins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5673000">
<property type="pathway name" value="RAF activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674135">
<property type="pathway name" value="MAP2K and MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5674499">
<property type="pathway name" value="Negative feedback regulation of MAPK pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802946">
<property type="pathway name" value="Signaling by moderate kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802948">
<property type="pathway name" value="Signaling by high-kinase activity BRAF mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802949">
<property type="pathway name" value="Signaling by RAS mutants"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802952">
<property type="pathway name" value="Signaling by BRAF and RAF fusions"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6802955">
<property type="pathway name" value="Paradoxical activation of RAF signaling by kinase inactive BRAF"/>
</dbReference>
<dbReference type="SignaLink" id="P36507"/>
<dbReference type="SIGNOR" id="P36507"/>
<dbReference type="ChiTaRS" id="MAP2K2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P36507"/>
<dbReference type="GeneWiki" id="MAP2K2"/>
<dbReference type="GenomeRNAi" id="5605"/>
<dbReference type="PMAP-CutDB" id="P36507"/>
<dbReference type="PRO" id="PR:P36507"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000126934"/>
<dbReference type="CleanEx" id="HS_MAP2K2"/>
<dbReference type="ExpressionAtlas" id="P36507">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P36507">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005911">
<property type="term" value="C:cell-cell junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005769">
<property type="term" value="C:early endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005783">
<property type="term" value="C:endoplasmic reticulum"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005794">
<property type="term" value="C:Golgi apparatus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005770">
<property type="term" value="C:late endosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005874">
<property type="term" value="C:microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005778">
<property type="term" value="C:peroxisomal membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004708">
<property type="term" value="F:MAP kinase kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030165">
<property type="term" value="F:PDZ domain binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043539">
<property type="term" value="F:protein serine/threonine kinase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0004712">
<property type="term" value="F:protein serine/threonine/tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004713">
<property type="term" value="F:protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0097110">
<property type="term" value="F:scaffold protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070371">
<property type="term" value="P:ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000165">
<property type="term" value="P:MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010629">
<property type="term" value="P:negative regulation of gene expression"/>
<property type="evidence" value="ECO:0000316"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036289">
<property type="term" value="P:peptidyl-serine autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070374">
<property type="term" value="P:positive regulation of ERK1 and ERK2 cascade"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071902">
<property type="term" value="P:positive regulation of protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035897">
<property type="term" value="P:proteolysis in other organism"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042981">
<property type="term" value="P:regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:2000641">
<property type="term" value="P:regulation of early endosome to late endosome transport"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090170">
<property type="term" value="P:regulation of Golgi inheritance"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007346">
<property type="term" value="P:regulation of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0032872">
<property type="term" value="P:regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0122">Cardiomyopathy</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0038">Ectodermal dysplasia</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<feature type="chain" description="Dual specificity mitogen-activated protein kinase kinase 2" id="PRO_0000086372">
<location>
<begin position="1"/>
<end position="400"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="72"/>
<end position="369"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="78"/>
<end position="86"/>
</location>
</feature>
<feature type="compositionally biased region" description="Pro-rich">
<location>
<begin position="266"/>
<end position="315"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="12 13">
<location>
<position position="194"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="12">
<location>
<position position="101"/>
</location>
</feature>
<feature type="site" description="Cleavage; by anthrax lethal factor">
<location>
<begin position="10"/>
<end position="11"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="4">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="O-acetylserine; by Yersinia yopJ; alternate" evidence="16">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RAF; alternate" evidence="14 16">
<location>
<position position="222"/>
</location>
</feature>
<feature type="modified residue" description="O-acetylserine; by Yersinia yopJ; alternate" evidence="16">
<location>
<position position="226"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; alternate" evidence="16">
<location>
<position position="226"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="293"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 5">
<location>
<position position="295"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="306"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 5 6 7 20">
<location>
<position position="394"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="2 6 7 8">
<location>
<position position="396"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC4; dbSNP:rs121434497." id="VAR_035095" evidence="15">
<original>F</original>
<variation>C</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC4; dbSNP:rs121434498." id="VAR_069781" evidence="17">
<original>F</original>
<variation>V</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC4; results in increased kinase activity; dbSNP:rs267607230." id="VAR_069782" evidence="19">
<original>P</original>
<variation>Q</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="sequence variant" description="In CFC4; dbSNP:rs121434499." id="VAR_069783" evidence="17">
<original>Y</original>
<variation>H</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AA sequence." ref="6" evidence="21">
<original>A</original>
<variation>R</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="69"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="72"/>
<end position="80"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="85"/>
<end position="91"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="92"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="97"/>
<end position="103"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="110"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="120"/>
<end position="122"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="133"/>
<end position="148"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="155"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="162"/>
<end position="164"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="167"/>
<end position="186"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="197"/>
<end position="199"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="200"/>
<end position="202"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="208"/>
<end position="210"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="217"/>
<end position="222"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="236"/>
<end position="239"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="246"/>
<end position="262"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="272"/>
<end position="279"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="318"/>
<end position="327"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="335"/>
<end position="337"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="340"/>
<end position="349"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="360"/>
<end position="364"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="367"/>
<end position="374"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="379"/>
<end position="386"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1S9I"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250"/>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q02750"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q63932"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10409742"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16439621"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17116858"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18042262"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19447520"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20358587"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="21" type="ECO:0000305"/>
<sequence length="400" mass="44424" checksum="3401D522515C30A5" modified="1994-06-01" version="1">
MLARRKPVLPALTINPTIAEGPSPTSEGASEANLVDLQKKLEELELDEQQKKRLEAFLTQ
KAKVGELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQ
VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG
LAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERLQ
GTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP
PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADL
KMLTNHTFIKRSEVEEVDFAGWLCKTLRLNQPGTPTRTAV
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>